Vaxxas's last reported valuation, Aug 2025. Nothing priced has surfaced since.
- ·The complete investor list: 22 names
- ·Watch Vaxxas: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Vaxxas funding history
No funding rounds for Vaxxas are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Vaxxas valuation
Vaxxas's last reported valuation was $236 million in Aug 2025. No priced round, secondary trade or fund mark has surfaced since.
How Vaxxas's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Vaxxas, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Vaxxas
- What is Vaxxas worth?
- Vaxxas is valued at $235.6M as of Oct 2026. Vaxxas's last reported valuation, Aug 2025. Nothing priced has surfaced since.
- How much has Vaxxas raised?
- Vaxxas has raised $154.3M in total funding across its recorded rounds.